Clinical Prediction Guides: Novel Enrichment Strategies Create New Partnering Opportunities

Posted by on Mar 3, 2009 in Publications | 0 comments

The promise of personalized medicine is having a profound impact on the healthcare industry. It promises to change the way healthcare is delivered and how drugs and diagnostics are developed. Pharma companies are still worried. They do not understand how this area will play out and are risk-averse to working in the brave new world of RxDx regulation. In addition, the ability to mine large databases for clinical, genetic, and prescription drug information must be balanced against an individual’s rights of privacy—yet another issue that must be resolved before the widespread use of personalized healthcare becomes a reality. In this report, we discuss business models, strategies, and opportunities from the perspective of multiple stakeholders.

Follow this link for the original article in Spectrum